Literature DB >> 10700177

Mutations in ACTN4, encoding alpha-actinin-4, cause familial focal segmental glomerulosclerosis.

J M Kaplan1, S H Kim, K N North, H Rennke, L A Correia, H Q Tong, B J Mathis, J C Rodríguez-Pérez, P G Allen, A H Beggs, M R Pollak.   

Abstract

Focal and segmental glomerulosclerosis (FSGS) is a common, non-specific renal lesion. Although it is often secondary to other disorders, including HIV infection, obesity, hypertension and diabetes, FSGS also appears as an isolated, idiopathic condition. FSGS is characterized by increased urinary protein excretion and decreasing kidney function. Often, renal insufficiency in affected patients progresses to end-stage renal failure, a highly morbid state requiring either dialysis therapy or kidney transplantation. Here we present evidence implicating mutations in the gene encoding alpha-actinin-4 (ACTN4; ref. 2), an actin-filament crosslinking protein, as the cause of disease in three families with an autosomal dominant form of FSGS. In vitro, mutant alpha-actinin-4 binds filamentous actin (F-actin) more strongly than does wild-type alpha-actinin-4. Regulation of the actin cytoskeleton of glomerular podocytes may be altered in this group of patients. Our results have implications for understanding the role of the cytoskeleton in the pathophysiology of kidney disease and may lead to a better understanding of the genetic basis of susceptibility to kidney damage.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10700177     DOI: 10.1038/73456

Source DB:  PubMed          Journal:  Nat Genet        ISSN: 1061-4036            Impact factor:   38.330


  421 in total

1.  A locus for an autosomal dominant form of progressive renal failure and hypertension at chromosome 1q21.

Authors:  D H Cohn; T Shohat; M Yahav; T Ilan; G Rechavi; L King; M Shohat
Journal:  Am J Hum Genet       Date:  2000-08-04       Impact factor: 11.025

Review 2.  Focusing on the glomerular slit diaphragm: podocin enters the picture.

Authors:  Jeffrey H Miner
Journal:  Am J Pathol       Date:  2002-01       Impact factor: 4.307

Review 3.  Genetic models: clues for understanding the pathogenesis of idiopathic nephrotic syndrome.

Authors:  Corinne Antignac
Journal:  J Clin Invest       Date:  2002-02       Impact factor: 14.808

Review 4.  Genetic basis of adult-onset nephrotic syndrome and focal segmental glomerulosclerosis.

Authors:  Jian Liu; Weiming Wang
Journal:  Front Med       Date:  2017-08-03       Impact factor: 4.592

5.  Rho activation of mDia formins is modulated by an interaction with inverted formin 2 (INF2).

Authors:  Hua Sun; Johannes S Schlondorff; Elizabeth J Brown; Henry N Higgs; Martin R Pollak
Journal:  Proc Natl Acad Sci U S A       Date:  2011-01-28       Impact factor: 11.205

Review 6.  Filamin structure, function and mechanics: are altered filamin-mediated force responses associated with human disease?

Authors:  Andrew J Sutherland-Smith
Journal:  Biophys Rev       Date:  2011-01-27

7.  Polymorphisms in the non-muscle myosin heavy chain 9 gene (MYH9) are strongly associated with end-stage renal disease historically attributed to hypertension in African Americans.

Authors:  Barry I Freedman; Pamela J Hicks; Meredith A Bostrom; Mary E Cunningham; Yongmei Liu; Jasmin Divers; Jeffrey B Kopp; Cheryl A Winkler; George W Nelson; Carl D Langefeld; Donald W Bowden
Journal:  Kidney Int       Date:  2009-01-28       Impact factor: 10.612

Review 8.  Genetic causes of proteinuria and nephrotic syndrome: impact on podocyte pathobiology.

Authors:  Oleh Akchurin; Kimberly J Reidy
Journal:  Pediatr Nephrol       Date:  2014-03-02       Impact factor: 3.714

9.  The Role of Palladin in Podocytes.

Authors:  Nadine Artelt; Tim A Ludwig; Henrik Rogge; Panagiotis Kavvadas; Florian Siegerist; Antje Blumenthal; Jens van den Brandt; Carol A Otey; Marie-Louise Bang; Kerstin Amann; Christos E Chadjichristos; Christos Chatziantoniou; Karlhans Endlich; Nicole Endlich
Journal:  J Am Soc Nephrol       Date:  2018-05-02       Impact factor: 10.121

Review 10.  Genetic testing in nephrotic syndrome--challenges and opportunities.

Authors:  Rasheed A Gbadegesin; Michelle P Winn; William E Smoyer
Journal:  Nat Rev Nephrol       Date:  2013-01-15       Impact factor: 28.314

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.